Evidence map›Paper›PMID 35069953›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2022

Virtual Healthcare Center for COVID-19 Patient Detection Based on Artificial Intelligence Approaches.

Seifeddine Messaoud, Soulef Bouaafia, Amna Maraoui, Lazhar Khriji, Ahmed Chiheb Ammari, Mohsen Machhout

Abstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Seifeddine MessaoudLaboratory of Electronics and Microelectronics, Faculty of Sciences, University of Monastir, Monastir, Tunisia.ORCID https://orcid.org/0000-0001-5205-4914
Soulef BouaafiaLaboratory of Electronics and Microelectronics, Faculty of Sciences, University of Monastir, Monastir, Tunisia.ORCID https://orcid.org/0000-0003-0657-6900
Amna MaraouiLaboratory of Electronics and Microelectronics, Faculty of Sciences, University of Monastir, Monastir, Tunisia.ORCID https://orcid.org/0000-0002-0448-4378
Lazhar KhrijiDepartment of Electrical and Computer Engineering, College of Engineering, Sultan Qaboos University, Muscat, Oman.ORCID https://orcid.org/0000-0002-1434-5689
Ahmed Chiheb AmmariDepartment of Electrical and Computer Engineering, College of Engineering, Sultan Qaboos University, Muscat, Oman.ORCID https://orcid.org/0000-0002-9939-1624
Mohsen MachhoutLaboratory of Electronics and Microelectronics, Faculty of Sciences, University of Monastir, Monastir, Tunisia.ORCID https://orcid.org/0000-0002-9378-9412

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the end of 2019, the infectious coronavirus disease (COVID-19) was reported for the first time in Wuhan, and, since then, it has become a public health issue in China and even worldwide. This pandemic has devastating effects on societies and economies around the world, and poor countries and continents are likely to face particularly serious and long-lasting damage, which could lead to large epidemic outbreaks because of the lack of financial and health resources. The increasing number of COVID-19 tests gives more information about the epidemic spread, and this can help contain the spread to avoid more infection. As COVID-19 keeps spreading, medical products, especially those needed to perform blood tests, will become scarce as a result of the high demand and insufficient supply and logistical means. However, technological tests based on deep learning techniques and medical images could be useful in fighting this pandemic. In this perspective, we propose a COVID-19 disease diagnosis (CDD) tool that implements a deep learning technique to provide automatic symptoms checking and COVID-19 detection. Our CDD scheme implements two main steps. First, the patient's symptoms are checked, and the infection probability is predicted. Then, based on the infection probability, the patient's lungs will be diagnosed by an automatic analysis of X-ray or computerized tomography (CT) images, and the presence of the infection will be accordingly confirmed or not. The numerical results prove the efficiency of the proposed scheme by achieving an accuracy value over 90% compared with the other schemes.

Identifiers

PMID35069953
PMCPMC8767384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.